𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term persistence of HBV DNA in chronic hepatitis patients successfully treated with interferon

✍ Scribed by J. Cianciara; M. Radkowski; T. Łoch; J. Kozłowska; A. Cybula

Book ID
118568451
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
160 KB
Volume
28
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistence of hepatitis C virus in pati
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C
✍ Marek Radkowski; Juan F. Gallegos-Orozco; Joanna Jablonska; Thomas V. Colby; Boz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

It is unclear whether the current antiviral treatment for chronic hepatitis C virus (HCV) infection results in complete elimination of the virus, or whether small quantities of virus persist. Our study group comprised 17 patients with chronic HCV who had sustained virological response (SVR) after in

Long-term follow-up of patients with chr
Long-term follow-up of patients with chronic hepatitis C treated with α-interferon
✍ Michiko Shindo; Adrian M. di Bisceglie; Jay H. Hoofnagle 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986

Virological and biochemical long-term fo
Virological and biochemical long-term follow-up of patients with chronic hepatitis c treated with interferon
✍ Inmaculada Castillo; Javier Bartolomé; Sonia Navas; Sara Gonzalez; Montserrat He 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

We studied the long-term outcomes of 43 patients with chronic hepatitis C treated with one or two interferon cycles, in relation to hepatitis C virus RNA in serum and peripheral-blood mononuclear cells. After the first interferon cycle, 15 (35%) patients had normal transaminase levels, although only